From IIEF-5 self-assessment and basic laboratory tests to NPTR nocturnal monitoring, objective assessment is the first step of scientific treatment; clinical evidence for WBL LIPUS continues to accumulate across mild-to-moderate and severe ED.

WBL debuted its LIPUS Academic Literature Collection at Special Booth A07, Golden Hall. Professor Li Zheng presented a 320-patient frequency study in mild-to-moderate ED and a 3-year follow-up study in severe ED, and signed copies on site. October 29 - November 1, 2026 · Shandong Building, Jinan

No drugs, no surgery — using extremely low-intensity mechanical signals to awaken the body's own repair workers. Understand WBL LIPUS micro-energy medicine in one article.

43 severe ED patients, 8 sessions, 3-year follow-up - Current Urology publishes the WBL LIPUS prospective study, with efficacy data and study limitations explained in full.

Prospective evidence in severe ED has long been scarce. In September 2026, a 3-year follow-up study of 43 patients with severe ED was published in the international urology journal Current Urology; the device documented in the study protocol is the WBL WBL-ED.

WBL is exhibiting with a special booth (A07), presenting five innovative devices. October 29 - November 1, 2026 · Shandong Building, Jinan · Specialists nationwide are cordially invited

A review of a 2026 randomized controlled trial of 112 ED patients published in the Chinese Journal of Andrology.

On October 17-18, 2026, the 2026 Annual Academic Conference of the Andrology and Men's Health Committee of the Chinese Non-Government Medical Institutions Association and the Second Annual Academic Conference of the Men's Health Committee of the Jiangsu Social-Run Medical Institutions Association were held concurrently at Taikang Xianlin Drum Tower Hospital in Nanjing. WBL Medical Group exhibited the LIPUS therapeutic device (Model B), the extracorporeal pulsed-ultrasound pelvic-floor therapeutic platform and the penile rigidity measurement device (JH-ED1100). In his report, Professor Zhai Xinyu of Shuguang Hospital shared preliminary data from 63 cases of LIPUS combined with the Shugan Fuyang Yiwei Patch for liver-qi stagnation-type ED.

From 15 to 17 October 2026, the 17th Women's and Children's Health Development Conference was held in Chengdu. WBL exhibited its LIPUS (low-intensity pulsed ultrasound) technology at Booth D06 and exchanged views with attending specialists on clinical applications in pelvic floor health.

A retrospective cohort study by the andrology team at Nanjing Drum Tower Hospital, Nanjing University Medical School, enrolled 48 patients with severe erectile dysfunction (ED) to compare two treatment pathways: WBL LIPUS alone versus LIPUS combined with tadalafil 10 mg daily. Both groups showed significant improvement from baseline in IIEF-EF scores and erection hardness, with the effect maintained at the 12-week follow-up. Among six patients who completed colour Doppler ultrasound, measurable improvements were seen in penile arterial flow parameters. No adverse events were recorded throughout treatment and follow-up.